Treating bipolar depression - Antidepressants and alternatives: A critical review of the literature

Acta Neuropsychiatrica

Volumn 23, Issue 3, 2011, Pages 94-105

  Tundo, Antonio ^a   Cavalieri, Paola ^a   Navari, Serena ^a,b   Marchetti, Fulvia ^a  

^a Institute of Psychopathology   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

antidepressants; bipolar disorder; depression; dopamine agonists; electroconvulsive therapy; mood stabilisers; psychotherapy

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; DESIPRAMINE; FLUOXETINE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LITHIUM CARBONATE; MOCLOBEMIDE; MODAFINIL; MOOD STABILIZER; OLANZAPINE; PAROXETINE; PRAMIPEXOLE; QUETIAPINE; RISPERIDONE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ADD ON THERAPY; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; HIGH RISK PATIENT; HUMAN; LITHIUM BLOOD LEVEL; MAJOR DEPRESSION; META ANALYSIS (TOPIC); OPEN STUDY; PSYCHOEDUCATION; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SIDE EFFECT; SUICIDAL BEHAVIOR; SYSTEMATIC REVIEW (TOPIC); TRANSCRANIAL MAGNETIC STIMULATION; WEIGHT GAIN;

EID: 79957487709     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2011.00542.x     Document Type: Review

References (148)

1. Goodwin GM., Prophylaxis of bipolar disorder: how and who should we treat in the long term? Eur Neuropsychopharmacol 1999; 9 (Suppl. 4): S125-S129. (Pubitemid 29397413)
2. Judd LL, Akiskal HS, Schettler PJ, et al., The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537. (Pubitemid 34602935)
3. Judd LL, Akiskal HS, Schettler PJ, et al., A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60: 261-269. (Pubitemid 36307437)
4. Baldassano CF, Ballas CA, O'Reardon JP., Rethinking the treatment paradigm for bipolar depression: the importance of long-term management. CNS Spectr 2004; 9 (Suppl. 9): 11-18.
5. Suppes T, Dennehy EB, Gibbons EW., The longitudinal course of bipolar disorder. J Clin Psychiatry 2000; 61 (Suppl. 9): 23-30. (Pubitemid 30453883)
6. Calabrese JR, Hirschfeld RM, Frye MA, Reed ML., Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample. J Clin Psychiatry 2004; 65: 1499-1504.
7. Ghaemi SN, Boiman EE, Goodwin FK., Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry 2000; 61: 804-808.
8. McIntyre RS, Muzina DJ, Kemp DE, et al., Bipolar disorder and suicide: research synthesis and clinical translation. Curr Psychiatry Rep 2008; 10: 66-72. (Pubitemid 351266372)
9. Yatham LN, Kennedy SH, Schaffer A, et al., Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009; 11: 225-255.
10. APA. Practice Guideline for the Treatment of Patients with Bipolar Disorder, 2002. URL (accessed on 2 February 2009).
11. Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK., Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 2003; 5: 421-433. (Pubitemid 38072244)
12. Goodwin FK, Jamison KR., Manic depressive illness and recurrent depression, 2nd edn. New York: Oxford University Press, 2007: 754-756.
13. Grunze H, Kasper S, Goodwin G, et al., World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: treatment of bipolar depression. World J Biol Psychiatry 2002; 3: 115-124.
14. Möller HJ, Grunze H., Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?. Eur Arch Psychiatry Clin Neurosci 2000; 250: 57-68. (Pubitemid 30326316)
15. Möller HJ, Grunze H, Broich K., Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review. Eur Arch Psychiatry Clin Neurosci 2006; 256: 1-16. (Pubitemid 43288239)
16. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM., Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004; 161: 1537-1547. (Pubitemid 39201448)
17. Mendlewicz J, Youdim MB., Antidepressant potentiation of 5-hydroxytryptophan by l-deprenil in affective illness. J Affect Disord 1980; 2: 137-146. (Pubitemid 10117157)
18. Himmelhoch JM, Fuchs CZ, Symons BJ., A double-blind study of tranylcypromine treatment of major anergic depression. J Nerv Ment Dis 1982; 170: 628-634. (Pubitemid 12036008)
19. Cohn JB, Collins G, Ashbrook E, Wernicke JF., A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989; 4: 313-322.
20. Nemeroff CB, Evans DL, Gyulai L, et al., Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001; 158: 906-912. (Pubitemid 32547620)
21. Tohen M, Vieta M, Calabrese E, Ketter J, et al., Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatr 2003; 60: 1079-1088. (Pubitemid 37429647)
22. Fabre LF, Brodie HK, Garver D, Zung WW., A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients. J Clin Psychiatry 1983; 44 (5 Pt 2): 88-94. (Pubitemid 13088844)
23. Merideth CH, Feighner JP., The use of bupropion in hospitalized depressed patients. J Clin Psychiatry 1983; 44 (5 Pt 2): 85-87. (Pubitemid 13088843)
24. Himmelhoch JM, Thase ME, Mallinger AG, Houck P., Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991; 148: 910-916.
25. Thase ME, Mallinger AG, McKnight D, Himmelhoch JM., Treatment of imipramine-resistant recurrent depression, IV: a double-blind crossover study of tranylcypromine for anergic bipolar depression. Am J Psychiatry 1992; 149: 195-198.
26. Silverstone T., Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial. Acta Psychiatr Scand 2001; 104: 104-109. (Pubitemid 32656085)
27. Sachs GS, Lafer B, Stoll AL, et al., A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994; 55: 391-393. (Pubitemid 24337995)
28. Vieta E, Martinez-Aran A, Goikolea JM, et al., A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 2002; 63: 508-512. (Pubitemid 34680359)
29. Post RM, Altshuler LL, Leverich GS, et al., Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006; 189: 124-131. (Pubitemid 44231270)
30. Frazier JA, Chiu S, Breeze JL, et al., Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry 2005; 162: 1256-1265. (Pubitemid 40905575)
31. Fisfalen ME, Schulze TG, DePaulo JR Jr, DeGroot LJ, Badner JA, McMahon FJ., Familial variation in episode frequency in bipolar affective disorder. Am J Psychiatry 2005; 162: 1266-1272. (Pubitemid 40905576)
32. Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ., Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2004; 161: 163-165. (Pubitemid 38419324)
33. Amsterdam JD, Garcia-Espana F., Venlafaxine monotherapy in women with bipolar II and unipolar major depression. J Affect Disord 2000; 59: 225-229. (Pubitemid 30347545)
34. Amsterdam J., Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. J Clin Psychopharmacol 1998; 18: 414-417. (Pubitemid 28462632)
35. Moller HJ, Bottlender R, Grunze H, Strauss A, Wittmann J., Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression? J Affect Disord 2001; 67: 141-146. (Pubitemid 34183344)
36. Bottlender R, Rudolf D, Jager M, Strauss A, Möller HJ., Are bipolar I depressive patients less responsive to treatment with antidepressants than unipolar depressive patients? Results from a case control study. Eur Psychiatry 2002; 17: 200-205. (Pubitemid 34987822)
37. Agosti V, Stewart JW., Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression. Int Clin Psychopharmacol 2007; 22: 309-311. (Pubitemid 47237550)
38. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I., Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157: 124-126. (Pubitemid 30027433)
39. Sachs GS, Nierenberg AA, Calabrese JR, et al., Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356: 1711-1722. (Pubitemid 46658703)
40. Brown EB, McElroy SL, Keck PE, et al., A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry 2006; 67: 1025-1033. (Pubitemid 44230872)
41. Goodwin FK, Jamison KR., Manic depressive illness and recurrent depression, 2nd edn. New York: Oxford University Press, 2007: 771-781.
42. Goldberg JF, Truman CJ., Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003; 5: 407-420 (Pubitemid 38072243)
43. Carlson GA, Finch SJ, Fochtmann LJ, et al., Antidepressant-associated switches from depression to mania in severe bipolar disorder. Bipolar Disord 2007; 9: 851-859. (Pubitemid 350215110)
44. Bauer M, Rasgon N, Grof P, et al., Mood changes related to antidepressants: a longitudinal study of patients with bipolar disorder in a naturalistic setting. Psychiatry Res 2005; 133: 73-80. (Pubitemid 40215473)
45. Frankle WG, Perlis RH, Deckersbach T, et al., Bipolar depression: relationship between episode length and antidepressant treatment. Psychol Med 2002; 32: 1417-1423. (Pubitemid 35385652)
46. Altshuler L, Suppes T, Black D, et al., Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003; 160: 1252-1262. (Pubitemid 41070941)
47. Angst J., Switch from depression to mania-a record study over decades between 1920 and 1982. Psychopathology 1985; 18: 140-154. (Pubitemid 16224274)
48. Bauer M, Rasgon N, Grof P, et al., Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder. Eur Psychiatry 2006; 21: 262-269. (Pubitemid 44202478)
49. Licht RW, Gijsman H, Nolen WA, Angst J., Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration. Acta Psychiatr Scand 2008; 118: 337-346.
50. Wehr TA, Goodwin FK., Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36: 555-559. (Pubitemid 9201187)
51. Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL., Bipolar depression and antidepressant-induced mania: a naturalistic study. J Clin Psychiatry 1998; 59: 374-379. (Pubitemid 28373104)
52. Peet M., Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164: 549-550. (Pubitemid 24141686)
53. Leverich GS, Altshuler LL, Frye MA, et al., Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006; 163: 232-239. (Pubitemid 44480842)
54. Shopsin B., Bupropion's prophylactic efficacy in bipolar affective illness. J Clin Psychiatry 1983; 44 (5 Pt 2): 163-169. (Pubitemid 13088859)
55. Wright G, Galloway L, Kim J, Dalton M, Miller L, Stern W., Bupropion in the long-term treatment of cyclic mood disorders: mood stabilizing effects. J Clin Psychiatry 1985; 46: 22-25. (Pubitemid 15156261)
56. Haykal RF, Akiskal HS., Bupropion as a promising approach to rapid cycling bipolar II patients. J Clin Psychiatry 1990; 51: 450-455.
57. Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M., Antidepressant- induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry 2001; 62: 249-255. (Pubitemid 32428763)
58. Bottlender R, Rudolf D, Strauss A, Moller HJ., Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression. Eur Arch Psychiatry Clin Neurosci 1998; 248: 296-300. (Pubitemid 29026985)
59. Goldberg JF, Whiteside JE., The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. J Clin Psychiatry 2002; 63: 791-795.
60. Stoll AL, Mayer PV, Kolbrener M, et al., Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry 1994; 151: 1642-1645. (Pubitemid 24337597)
61. Serretti A, Artioli P, Zanardi R, Rossini D., Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 751-757. (Pubitemid 36966755)
62. Manwani SG, Pardo TB, Albanese MJ, Zablotsky B, Goodwin FK, Ghaemi SN., Substance use disorder and other predictors of antidepressant-induced mania: a retrospective chart review. J Clin Psychiatry 2006; 67: 1341-1345. (Pubitemid 44583380)
63. Mundo E, Cattaneo E, Russo M, Altamura AC., Clinical variables related to antidepressant-induced mania in bipolar disorder. J Affect Disord 2006; 92: 227-230. (Pubitemid 44269309)
64. Frye MA, Helleman G, McElroy SL, et al., Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry 2009; 166: 164-172.
65. Bottlender R, Sato T, Kleindienst N, Strauss A, Moller HJ., Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder. J Affect Disord 2004; 78: 149-152. (Pubitemid 38045474)
66. Bond DJ, Noronha MM, Kauer-Sant'Anna M, Lam RW, Yatham LN., Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. J Clin Psychiatry 2008; 69: 1589-1601.
67. Salvi V, Fagiolini A, Swartz HA, Maina G, Frank E., The use of antidepressants in bipolar disorder. J Clin Psychiatry 2008; 69: 1307-1318.
68. MHRA. Safety of Selective Serotonin Reuptake Inhibitor Antidepressant, 2004. URL (accessed on 9 March 2009).
69. Fergusson D, Doucette S, Glass KC, et al., Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 2005; 330: 396.
70. Baldessarini RJ, Pompili M, Tondo L., Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry 2006; 63: 246-248. (Pubitemid 43345347)
71. Gibbons RD, Hur K, Bhaumik DK, Mann JJ., The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 2005; 62: 165-172. (Pubitemid 40189132)
72. Gunnell D, Saperia J, Ashby D., Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005; 330: 385.
73. Yerevanian BI, Koek RJ, Mintz J, Akiskal HS., Bipolar pharmacotherapy and suicidal behavior. Part 2. The impact of antidepressants. J Affect Disord 2007; 103: 13-21. (Pubitemid 47445779)
74. McElroy SL, Kotwal R, Kaneria R, Keck PE Jr., Antidepressants and suicidal behavior in bipolar disorder. Bipolar Disord 2006; 8 (5 Pt 2): 596-617. (Pubitemid 44567142)
75. Bauer MS, Wisniewski SR, Kogan JN, Marangell LB, Thase ME, Sachs G., Brief report: paroxetine in younger and adult individuals at high risk for suicide. Psychopharmacol Bull 2006; 39: 31-37.
76. Bauer MS, Wisniewski SR, Marangell LB, et al., Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 2006; 67: 48-55. (Pubitemid 43213282)
77. Tondo L, Lepri B, Baldessarini RJ., Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder. Acta Psychiatr Scand 2008; 118: 106-115. (Pubitemid 351962155)
78. Ghaemi SN, Wingo AP, Filkowski MA, Baldessarini RJ., Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr Scand 2008; 118: 347-356.
79. Altshuler L, Kiriakos L, Calcagno J, et al., The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry 2001; 62: 612-616. (Pubitemid 32848165)
80. Joffe RT, MacQueen GM, Marriott M, Young LT., One-year outcome with antidepressant-treatment of bipolar depression. Acta Psychiatr Scand 2005; 112: 105-109. (Pubitemid 41003188)
81. Altshuler LL, Post RM, Hellemann G, et al., Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. J Clin Psychiatry 2009; 70: 450-457.
82. Grunze HC., Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation? CNS Spectr 2008; 13: 790-795.
83. Ghaemi SN., Treatment of rapid-cycling bipolar disorder: are antidepressants mood destabilizers? Am J Psychiatry 2008; 165: 300-302. (Pubitemid 351704480)
84. Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak DV., Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients: a double-blind study. Arch Gen Psychiatry 1981; 38: 902-907. (Pubitemid 11040135)
85. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW., Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145: 179-184. (Pubitemid 18058361)
86. Kupka RW, Luckenbaugh DA, Post RM, et al., Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry 2005; 162: 1273-1280. (Pubitemid 40905577)
87. Altshuler LL, Post RM, Leverich GS, Mika-lauskas K, Rosoff A, Ackerman L., Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152: 1130-1138.
88. Kupfer DJ, Carpenter LL, Frank E., Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. Am J Psychiatry 1988; 145: 804-808.
89. Tondo L, Laddomada P, Serra G, Minnai G, Kukopulos A., Rapid cyclers and antidepressants. Int Pharmacopsychiatry 1981; 16: 119-123. (Pubitemid 11022634)
90. Kukopulos A, Caliari B, Tundo A, et al., Rapid cyclers, temperament, and antidepressants. Compr Psychiatry 1983; 24: 249-258. (Pubitemid 13059843)
91. Hurowitz GI, Liebowitz MR., Antidepressant-induced rapid cycling: six case reports. J Clin Psychopharmacol 1993; 13: 52-56. (Pubitemid 23030360)
92. Coryell W, Solomon D, Turvey C, et al., The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 2003; 60: 914-920. (Pubitemid 37122311)
93. Mattes JA., Antidepressant-induced rapid cycling: another perspective. Ann Clin Psychiatry 2006; 18: 195-199. (Pubitemid 44576441)
94. Mendels J, Frazer A., Intracellular lithium concentration and clinical response: towards a membrane theory of depression. J Psychiatr Res 1973; 10: 9-18.
95. Goodwin FK, Murphy DL, Dunner DL, Bunney WE Jr., Lithium response in unipolar versus bipolar depression. Am J Psychiatry 1972; 129: 44-47.
96. Baron M, Gershon ES, Rudy V, Jonas WZ, Buchsbaum M., Lithium carbonate response in depression: prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry 1975; 32: 1107-1111.
97. Noyes R Jr, Dempsey GM., Lithium treatment of depression. Dis Nerv Syst 1974; 35: 573-576.
98. Mendels J., Lithium in the treatment of depression. Am J Psychiatry 1976; 133: 373-378.
99. Donnelly EF, Goodwin FK, Waldman IN, Murphy DL., Prediction of antidepressant responses to lithium. Am J Psychiatry 1978; 135: 552-556. (Pubitemid 8329023)
100. Tondo L, Baldessarini RJ., Reduced suicide risk during lithium maintenance treatment. J Clin Psychiatry 2000; 61 (Suppl. 9): 97-104. (Pubitemid 30453892)
101. Lauterbach E, Felber W, Muller-Oerlinghausen B, et al., Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand 2008; 118: 469-479.
102. Carney SM, Goodwin GM., Lithium-a continuing story in the treatment of bipolar disorder. Acta Psychiatr Scand Suppl 2005; 426: 7-12. (Pubitemid 40604344)
103. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM., Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004; 161: 217-222. (Pubitemid 38419270)
104. Smith LA, Cornelius V, Warnock A, Bell A, Young AH., Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord 2007; 9: 394-412. (Pubitemid 46876306)
105. Geddes JR, Calabrese JR, Goodwin GM., Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 2009; 194: 4-9.
106. Suppes T, Marangell LB, Bernstein IH, et al., A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J Affect Disord 2008; 111: 334-343.
107. van der Loos ML, Mulder PG, Hartong EG, et al., Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry 2009; 70: 223-231.
108. van der Loos ML, Kolling P, Knoppert-van der Klein EA, Nolen WA., [Lamotrigine in the treatment of bipolar disorder, a review]. Tijdschr Psychiatr 2007; 49: 95-103. (Pubitemid 46276949)
109. Calabrese JR, Huffman RF, White RL, et al., Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008; 10: 323-333. (Pubitemid 351637697)
110. Davis LL, Bartolucci A, Petty F., Divalproex in the treatment of bipolar depression: a placebo-controlled study. J Affect Disord 2005; 85: 259-266. (Pubitemid 40386509)
111. Ghaemi SN, Gilmer WS, Goldberg JF, et al., Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study. J Clin Psychiatry 2007; 68: 1840-1844.
112. Gyulai L, Bowden CL, McElroy SL, et al., Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology 2003; 28: 1374-1382. (Pubitemid 41070909)
113. Kemp DE, Keming G, Calabrese JR., Antiepilectic drugs in the treatment of rapid-cycling bipolar disorder and bipolar depression. In:, McElroy S, Keck PE Jr, Post RM, eds. Antiepilectic drugs to treat psychiatric disorders. London: Informa Healthcare, 2008: 155-176.
114. Wang PW, Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA., Gabapentin augmentation therapy in bipolar depression. Bipolar Disord 2002; 4: 296-301.
115. Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G., Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy, Gabapentin Bipolar Disorder Study Group Bipolar Disord 2000; 2 (3 Pt 2): 249-255.
116. Vieta E, Torrent C, Garcia-Ribas G, et al., Use of topiramate in treatment-resistant bipolar spectrum disorders. J Clin Psychopharmacol 2002; 22: 431-435. (Pubitemid 34810336)
117. McElroy SL, Suppes T, Keck PE, et al., Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000; 47: 1025-1033. (Pubitemid 30336210)
118. Zarate CA Jr, Payne JL, Singh J, et al., Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry 2004; 56: 54-60. (Pubitemid 38813406)
119. Lattanzi L, Dell'Osso L, Cassano P, et al., Pramipexole in treatment-resistant depression: a 16-week naturalistic study. Bipolar Disord 2002; 4: 307-314.
120. Goldberg JF, Burdick KE, Endick CJ., Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry 2004; 161: 564-566. (Pubitemid 38326114)
121. Aiken CB., Pramipexole in psychiatry: a systematic review of the literature. J Clin Psychiatry 2007; 68: 1230-1236. (Pubitemid 47395626)
122. Frye MA, Grunze H, Suppes T, et al., A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 2007; 164: 1242-1249. (Pubitemid 47292414)
123. Nierenberg AA., Combined olanzapine plus fluoxetine modestly improves symptoms of acute bipolar I depression compared to lamotrigine. Evid Based Ment Health 2007; 10: 12.
124. Brown E, Dunner DL, McElroy SL, et al., Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. Int J Neuropsychopharmacol 2009; 12: 773-782.
125. Calabrese JR, Keck PE Jr, Macfadden W, et al., A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162: 1351-1360. (Pubitemid 40905587)
126. Thase ME, Macfadden W, Weisler RH, et al., Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 2006; 26: 600-609. (Pubitemid 44772737)
127. Weisler RH, Calabrese JR, Thase ME, et al., Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies. J Clin Psychiatry 2008; 69: 769-782. (Pubitemid 351838686)
128. Cookson J, Keck PE Jr, Ketter TA, Macfadden W., Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. Int Clin Psychopharmacol 2007; 22: 93-100.
129. Endicott J, Rajagopalan K, Minkwitz M, Macfadden W., A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life. Int Clin Psychopharmacol 2007; 22: 29-37. (Pubitemid 44950765)
130. Endicott J, Paulsson B, Gustafsson U, Schioler H, Hassan M., Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep. J Affect Disord 2008; 111: 306-319.
131. Shelton RC, Stahl SM., Risperidone and paroxetine given singly and in combination for bipolar depression. J Clin Psychiatry 2004; 65: 1715-1719.
132. Vieta E, Goikolea JM, Corbella B, et al., Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J Clin Psychiatry 2001; 62: 818-825. (Pubitemid 33104669)
133. McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH., The antidepressant effects of risperidone and olanzapine in bipolar disorder. Can J Clin Pharmacol 2004; 11: e218-e226. (Pubitemid 46333118)
134. Thase ME, Jonas A, Khan A, et al., Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. J Clin Psychopharmacol 2008; 28: 13-20.
135. Kemp DE, Dago PL, Straus JL, Fleck J, Karaffa M, Gilmer WS., Aripiprazole augmentation for treatment-resistant bipolar depression: sustained remission after 36 months. J Clin Psychopharmacol 2007; 27: 304-305. (Pubitemid 46763316)
136. Kemp DE, Gilmer WS, Fleck J, Straus JL, Dago PL, Karaffa M., Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 574-577. (Pubitemid 46209454)
137. Black DW, Winokur G, Nasrallah A., The treatment of depression: electroconvulsive therapy v antidepressants: a naturalistic evaluation of 1,495 patients. Compr Psychiatry 1987; 28: 169-182. (Pubitemid 17045409)
138. Zorumski CF, Rutherford JL, Burke WJ, Reich T., ECT in primary and secondary depression. J Clin Psychiatry 1986; 47: 298-300. (Pubitemid 16062285)
139. Russell JC, Rasmussen KG, O'Connor MK, Copeman CA, Ryan DA, Rummans TA., Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J ECT 2003; 19: 4-9. (Pubitemid 36298274)
140. Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA., Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry 2004; 55: 301-312. (Pubitemid 38117168)
141. UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361: 799-808.
142. Maletzky BM., The first-line use of electroconvulsive therapy in major affective disorders. J ECT 2004; 20: 112-117. (Pubitemid 38747573)
143. Dolberg OT, Dannon PN, Schreiber S, Grunhaus L., Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study. Bipolar Disord 2002; 4 (Suppl. 1): 94-95.
144. Nahas Z, Kozel FA, Li X, Anderson B, George MS., Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord 2003; 5: 40-47. (Pubitemid 36621632)
145. Tamas RL, Menkes D, El-Mallakh RS., Stimulating research: a prospective, randomized, double-blind, sham-controlled study of slow transcranial magnetic stimulation in depressed bipolar patients. J Neuropsychiatry Clin Neurosci 2007; 19: 198-199. (Pubitemid 46649650)
146. Dell'Osso B, Mundo E, D'Urso N, et al., Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression. Bipolar Disord 2009; 11: 76-81.
147. Swartz HA, Frank E, Frankel DR, Novick D, Houck P., Psychotherapy as monotherapy for the treatment of bipolar II depression: a proof of concept study. Bipolar Disord 2009; 11: 89-94.
148. Miklowitz DJ., Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry 2008; 165: 1408-1419.